Incannex Healthcare Inc

IXHL

Company Profile

  • Business description

    Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

  • Contact

    8 Century Circuit Norwest
    Suite 105
    SydneyNSW3000
    AUS

    T: +61 409840786

    https://www.incannex.com.au

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    30 June 2026

    Employees

    9

Stocks News & Analysis

stocks

Wildly overvalued ASX stock is skating on thin ice

This company dominates its industry and could be flirting with regulatory intervention.
stocks

Uber flexes its network effect and delivers strong result

Uber’s business is humming along but autonomous vehicles add uncertainty to the longer term outlook.
stocks

Ask the analyst: Are Qantas shares a value trap?

Qantas’ pandemic woes seem a distant memory. But could the party end sooner than investors think?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,102.009.10-0.10%
CAC 407,717.5282.491.08%
DAX 4024,249.13324.771.36%
Dow JONES (US)44,048.03145.09-0.33%
FTSE 1009,108.4355.88-0.61%
HKSE25,081.63171.000.69%
NASDAQ21,320.72151.300.71%
Nikkei 22541,059.15264.290.65%
NZX 50 Index12,887.106.940.05%
S&P 5006,359.3914.330.23%
S&P/ASX 2008,831.4012.30-0.14%
SSE Composite Index3,639.675.670.16%

Market Movers